Indigo carmine
Drug
Provepharm Inc.
Total Payments
$13,902
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $13,902 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $13,902 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PVP-IC1901 | Provepharm Inc. | $13,902 | 0 |
Top Doctors Receiving Payments for Indigo carmine
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Albany, NY | $13,902 | 2 |
Ad
Manufacturing Companies
- Provepharm Inc. $13,902
Product Information
- Type Drug
- Total Payments $13,902
- Total Doctors 0
- Transactions 2
About Indigo carmine
Indigo carmine is a drug associated with $13,902 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Provepharm Inc..
Payment data is available from 2020 to 2020. In 2020, $13,902 was paid across 2 transactions to 0 doctors.
The most common payment nature for Indigo carmine is "Unspecified" ($13,902, 100.0% of total).
Indigo carmine is associated with 1 research study, including "PVP-IC1901" ($13,902).